Hypothesis

The aging program is driven by a nuclear complex that couples mitochondrial metabolites to epigenetic state.

Mechanistic Basis

• The complex contains HDAC2 and the histone demethylase KDM5B.
• Its activity requires α‑ketoglutarate (α‑KG) produced by the TCA cycle.
• When mitochondrial output falls, α‑KG drops, reducing demethylase activity and increasing HDAC2‑mediated deacetylation.
• This shifts histone marks toward a repressed, aged epigenetic landscape.
• The shift propagates to downstream hallmarks: DNA methylation clocks advance, senescence markers rise, proteostasis falters, and genomic instability accumulates.

Testable Predictions

1. Genetic overexpression of KDM5B in aged mice will restore youthful histone methylation patterns without altering mitochondrial respiration, and will delay multiple hallmarks.
2. Pharmacological elevation of α‑KG (via cell‑permeable ester) will rescue the complex’s demethylase activity and reverse epigenetic clock acceleration even when mitochondrial function is inhibited.
3. CRISPR‑mediated disruption of the HDAC2‑KDM5B interaction will uncouple epigenetic drift from mitochondrial decline, leading to dissociation of methylation clock speed from physiological stress.

Falsification

If manipulation of the complex fails to affect more than one hallmark simultaneously, or if changes in α‑KG do not modify epigenetic marks in vivo, the hypothesis is falsified.

Supporting Evidence

Partial reprogramming with OSKM resets the complex indirectly by restoring NAD+ levels and α‑KG production, which aligns with observed simultaneous reversal of epigenetic erosion, senescence, and clock advancement [https://doi.org/10.1016/j.cell.2016.11.052]. Moreover, caloric restriction and rapamycin slow methylation clocks while boosting mitochondrial α‑KG output [https://pmc.ncbi.nlm.nih.gov/articles/PMC6520108/], consistent with a metabolite‑sensing regulator.